南華早報US regulator investigates tumour risk in children given Novartis gene therapy
來源 路透社全文約 2,414 字
文章摘要
南華早報 · 文章頁摘要FDA says Zolgensma’s benefits still outweigh risks, but weighs action after nine tumour cases emerge among 6,000 treated infants.
The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated w...